Table 3.
Potential benefit | |
---|---|
Negligible risk of severe hypoglycaemia | |
Reduction in insulin requirement | |
Cardiovascular protection | |
Attenuated glycaemic variability | |
Amenable to continuous infusion without dose titration | |
Decreased blood glucose testing | |
Simplified protocol for medical and nursing staff |